Changjin Bio 昌进生物 (Shanghai)
Harnessing the power of microflora, Changing Bio is on a mission to efficiently unlimiting nutritional potential with limited resources. With expertise in both biomass fermentation and precision fermentation, Changing Bio produces tasteful and versatile non-GMO mycoproteins, as well as a series of dairy proteins, utilizing proprietary strains in a controlled and efficient manner. Compared to …
Profile
Shanghai Changjin Biotechnology (Changjin Bio) is a Chinese food technology company founded in 2017 and headquartered in Shanghai’s Zhang江 Science City. It specializes in synthetic biology, focusing on the research, development, and industrialization of microbial biomass proteins and recombinant milk proteins.
The company’s core technology utilizes precision fermentation to produce proteins, such as beta-lactoglobulin and Kluyveromyces marxianus microbial protein, which are used in food products like protein crisps, cookies, and dairy alternatives. Its subsidiary brand, Chuangshenghuo, markets these as “yuan protein” products.
Changjin Bio is active as of September 2026. In October 2025, its beta-lactoglobulin and Kluyveromyces marxianus protein received U.S. market access via FDA GRAS status. The company has secured nearly 300 million RMB in funding across multiple rounds from investors including Hillhouse Investment and Sherpa Invest. It operates a production facility in Qingdao and maintains various international certifications, including FSSC22000, BRC, and Halal.
Sources#
- http://chgbio.com/
- 昌进生物：筹划新一轮融资为扩产作准备 - 可持续食品新闻 — 2026-09-07
- 上海昌进生物科技有限公司_主要人员 - 企查查
- Shanghai Changjin Biotechnology Co., Ltd. Asset Profile | Preqin
- Shanghai Changjin Biotechnology Co Ltd - Company Profile and News - Bloomberg Markets
- 昌进生物产品成为中国第一例获得美国市场准入的食用合成蛋白产品和第一例微生物蛋白产品 - 可持续食品新闻 — 2024-11-11
- Changing Bio
- Changjin Biology - Products, Competitors, Financials, Employees, Headquarters Locations — 2023-06-06
- Industry
- Energy, Food ingredients, Waste & circular economy
- Topics
- Precision fermentation (proteins, dairy, egg), Biomass, bagasse & waste valorisation, Yeast, fermentation & food ingredients
- Role
- Producer — “…st [2][7][8]. It operates a production facility in Qingdao and maintains various international certifications,…”
Bio-solutions it supplies 1
What they offer
Subsidiaries: Qingdao Changjin Biotechnology Co., Ltd. (Qingdao 昌进生物科技有限公司)
News & status 6
- 2026-09-28 上海昌进生物科技有限公司两项产品获SIAL创新大奖
_消费日报网Changjin Bio (Shanghai Changjin Biotech) is a national high-tech食品 company focusing on microbial and synthetic protein R&D and industrialization; its products include LOOOOB! high-protein water and a black-truffle cheese-flavored hazelnut snack that won SIAL …
- 2026-09-07 昌进生物：筹划新一轮融资为扩产作准备 - 可持续食品新闻Changjin Bio (Shanghai) is a leading synthetic biology-focused food company applying microbial and protein-synthesis tech to produce high-quality, precision-nutrition proteins (including beta-lactoglobulin and microbial proteins). It has secured US market …
- 2026-07-31 合成生物企业「昌进生物」获A+轮融资，新型蛋白即将投放市场 | 36氪独家-36氪Changjin Bio (昌进生物) based in Shanghai is mentioned in the context of Volcano Engine (火山引擎) and related security checks; the content does not provide specific details about the company’s activities or status. In short: it references Changjin Bio in relation to …
- 2026-03-20 「昌进生物」获1.4亿元A轮融资，新型蛋白实现5吨规模放大生产 | 36氪首发-36氪Changjin Bio (昌进生物) is a Shanghai microbiology company that has secured 140 million CNY in Series A funding from leading investors, and has achieved a 5-ton scale production line for a novel microbial protein, with plans for six 50-ton lines and a 6,000-ton …
- 2026-08-07 展商动态 | 不用养牛，不种牧草！上海昌进用微生物量产牛奶乳蛋白-世展网Changjin Bio (Shanghai Changjin Biotech) uses fermentation with engineered microbes to produce milk proteins (β-lactoglobulin, casein-like proteins) without raising cows, claiming production in days with yields comparable to years of dairy farming, and aiming …
- 2026-06-03 昌进生物、辉文生物申请人源胶原制备相关专利，利用β - 乳球蛋白高产有护肤功效人源Ⅲ型胶_新浪财经_新浪网Changjin Bio (Shanghai Changjin Biotechnology) is developing and collaborating on a patent for producing human-type III collagen using beta-lactoglobulin as a guiding protein to achieve high-yield production (reported at over 15 g/L) for skincare applications. …
Network: owners, partners, peers
Ownership & investors 5
| investor | GL Ventures |
| investor | Qingdao City Construction Investment Financial Holdings |
| investor | Bits x Bites |
| investor | Hillhouse/高瓴系 |
| subsidiary | Qingdao Changjin Biotechnology Co., Ltd |
Similar companies
SYNAURA Biotech · Yakult Honsha Co., Ltd. · Laurus Bio · 黑龙江康普生物科技有限公司 · FEBICO遠東生技 · Zhuhai TXY Biotech Holding Co., Ltd. · CJ BIO Taste & Nutrition Indonesia · Eppen Biotech
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member